[Promising new drugs in the treatment of ovarian cancer, and of gynecologic tumors, in general].
Di Leo
A
A
Unité Chimiothérapie, Institut Jules Bordet, Association Hospitalière de Bruxelles, Centre des Tumeurs de l'ULB, Belgium.
D000256:Adenoviridae; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D010880:Piperidines / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D016159:Tumor Suppressor Protein p53 / Q000235:genetics; D003986:Dibenzocycloheptenes
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D010880:Piperidines; D011725:Pyridines; D016159:Tumor Suppressor Protein p53; C115354:lonafarnib; D003986:Dibenzocycloheptenes